Name | (3S,4R)-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid,hydrochloride |
---|---|
Synonyms |
R 50,547
levocabastin Livostin LEVOCABASTINE HYDROCHLORIDE Levocabastine HCl Levocabastine Levophta levocobastine UNII-124XMA6YEI |
Description | Levocabastine (R 50547) hydrochloride is a long acting, highly potent and selective histamine H1-receptor antagonist with anti-allergic activity. Levocabastine hydrochloride is also a selective, high affinity neurotensin receptor subtype 2 (NTR2) antagonist, with a Ki of 17 nM for mNTR2[1][2]. |
---|---|
Related Catalog | |
Target |
H1 Receptor NTR2:17 nM (Ki) |
In Vivo | Levocabastine (0.25 mg/kg; i.p.; twice a day for five successive days; guinea-pigs) inhibits the virus-induced airway hyperresponsiveness, suppresses the influx of broncho-alveolar cells and increase in albumin content, and corrects the reduced chemiluminescence production by broncho-alveolar cells in response to zymosan[1]. In mice that receivedβ-LT, Levocabastine (0.05 mg/kg; i.p.) blocks the anxiolytic effect of β-LT and the number of head-dips decreased[2]. |
References |
Boiling Point | 611ºC at 760 mmHg |
---|---|
Molecular Formula | C26H30ClFN2O2 |
Molecular Weight | 456.98000 |
Flash Point | 323.3ºC |
Exact Mass | 456.19800 |
PSA | 64.33000 |
LogP | 5.63398 |
Appearance | solid | white |
Storage condition | 2-8°C |
Water Solubility | DMSO: ~10 mg/mL, soluble |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H315-H319-H335 |
Precautionary Statements | P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xi |
Risk Phrases | 36/37/38 |
Safety Phrases | 26-36 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |